Institution
St Thomas' Hospital
Healthcare•London, United Kingdom•
About: St Thomas' Hospital is a healthcare organization based out in London, United Kingdom. It is known for research contribution in the topics: Population & Pregnancy. The organization has 12105 authors who have published 15596 publications receiving 624309 citations. The organization is also known as: St Thomas's Hospital & St. Thomas's.
Topics: Population, Pregnancy, Antiphospholipid syndrome, Medicine, Cancer
Papers published on a yearly basis
Papers
More filters
••
TL;DR: It is concluded that the rapid increase in twitch force after muscle stretch is due to the length‐ dependent properties of the myofibrils, and that the slow force responses result from increased Ca2+ loading of the cell during the action potential.
Abstract: 1. Changes in cytosolic [Ca2+] ([Ca2+]i) were measured in isolated rat trabeculae that had been micro-injected with fura-2 salt, in order to investigate the mechanism by which twitch force changes following an alteration of muscle length. 2. A step increase in length of the muscle produced a rapid potentiation of twitch force but not of the Ca2+ transient. The rapid rise of force was unaffected by inhibiting the sarcoplasmic reticulum (SR) with ryanodine and cyclopiazonic acid. 3. The force-[Ca2+]i relationship of the myofibrils in situ, determined from twitches and tetanic contractions in SR-inhibited muscles, showed that the rapid rise of force was due primarily to an increase in myofibrillar Ca2+ sensitivity, with a contribution from an increase in the maximum force production of the myofibrils. 4. After stretch of the muscle there was a further, slow increase of twitch force which was due entirely to a slow increase of the Ca2+ transient, since there was no change in the myofibrillar force-[Ca2+]i relationship. SR inhibition slowed down, but did not alter the magnitude of, the slow force response. 5. During the slow rise of force there was no slow increase of diastolic [Ca2+]i, whether or not the SR was inhibited. The same was true in unstimulated muscles. 6. We conclude that the rapid increase in twitch force after muscle stretch is due to the length-dependent properties of the myofibrils. The slow force increase is not explained by length dependence of the myofibrils or the SR, or by a rise in diastolic [Ca2+]i. Evidence from tetani suggests the slow force responses result from increased Ca2+ loading of the cell during the action potential.
191 citations
••
Yale University1, NewYork–Presbyterian Hospital2, University of Alcalá3, Beth Israel Deaconess Medical Center4, Harvard University5, University of Insubria6, University of Texas Health Science Center at Houston7, Chinese PLA General Hospital8, University of Liverpool9, Huazhong University of Science and Technology10, Jean Monnet University11, Veterans Health Administration12, Leonard Davis Institute of Health Economics13, Hospital of the University of Pennsylvania14, University of Vermont15, University of Montpellier16, Westmead Hospital17, Loyola University Medical Center18, University of Chicago19, NorthShore University HealthSystem20, University of Milan21, Auckland City Hospital22, St Thomas' Hospital23, Hofstra University24, University of Michigan25, Population Health Research Institute26, I.M. Sechenov First Moscow State Medical University27, McMaster University28, Ottawa Hospital Research Institute29, Brigham and Women's Hospital30, Vanderbilt University31, Icahn School of Medicine at Mount Sinai32, University of Cologne33, Universidad Católica San Antonio de Murcia34, University of Mainz35, Aalborg University36
TL;DR: Novel dosing approaches are described for commonly used antithrombotic agents (especially heparin-based regimens) and the potential use of less widely used antithsombotic drugs in the absence of confirmed thrombosis.
Abstract: Coronavirus disease 2019 (COVID-19), currently a worldwide pandemic, is a viral illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The suspected contribution of thrombotic events to morbidity and mortality in COVID-19 patients has prompted a search for novel potential options for preventing COVID-19-associated thrombotic disease. In this article by the Global COVID-19 Thrombosis Collaborative Group, we describe novel dosing approaches for commonly used antithrombotic agents (especially heparin-based regimens) and the potential use of less widely used antithrombotic drugs in the absence of confirmed thrombosis. Although these therapies may have direct antithrombotic effects, other mechanisms of action, including anti-inflammatory or antiviral effects, have been postulated. Based on survey results from this group of authors, we suggest research priorities for specific agents and subgroups of patients with COVID-19. Further, we review other agents, including immunomodulators, that may have antithrombotic properties. It is our hope that the present document will encourage and stimulate future prospective studies and randomized trials to study the safety, efficacy, and optimal use of these agents for prevention or management of thrombosis in COVID-19.
191 citations
••
TL;DR: A meta-analysis of 139,555 Europeans identifies 68 new genomic loci associated with intraocular pressure, 68 of which are novel, which suggest a strong role for angiopoietin-receptor tyrosine kinase signaling, lipid metabolism, mitochondrial function and developmental processes underlying risk for elevated IOP.
Abstract: Glaucoma is the leading cause of irreversible blindness globally 1 . Despite its gravity, the disease is frequently undiagnosed in the community 2 . Raised intraocular pressure (IOP) is the most important risk factor for primary open-angle glaucoma (POAG)3,4. Here we present a meta-analysis of 139,555 European participants, which identified 112 genomic loci associated with IOP, 68 of which are novel. These loci suggest a strong role for angiopoietin-receptor tyrosine kinase signaling, lipid metabolism, mitochondrial function and developmental processes underlying risk for elevated IOP. In addition, 48 of these loci were nominally associated with glaucoma in an independent cohort, 14 of which were significant at a Bonferroni-corrected threshold. Regression-based glaucoma-prediction models had an area under the receiver operating characteristic curve (AUROC) of 0.76 in US NEIGHBORHOOD study participants and 0.74 in independent glaucoma cases from the UK Biobank. Genetic-prediction models for POAG offer an opportunity to target screening and timely therapy to individuals most at risk.
191 citations
••
TL;DR: These studies show the psychometric properties of the CAM and support its validity as a measure of cancer awareness in the general population.
Abstract: BACKGROUND: We aimed to develop and validate a measurement tool to assess cancer awareness in the general population: the cancer awareness measure (CAM).METHODS: Items assessing awareness of cancer warning signs, risk factors, incidence, screening programmes and attitudes towards help seeking were extracted from the literature or generated by expert groups. To determine reliability, the CAM was administered to a university participant panel (n = 148), with a sub-sample (n = 94) completing it again 2 weeks later. To establish construct validity, CAM scores of cancer experts (n = 12) were compared with those of non-medical academics (n = 21). Finally, university students (n = 49) were randomly assigned to read either a cancer information leaflet or a leaflet with control information before completing the measure, to ensure the CAM was sensitive to change.RESULTS: Cognitive interviewing indicated that the CAM was being interpreted as intended. Internal reliability (Cronbach's alpha = 0.77) and test-retest reliability (r = 0.81) were high. Scores for cancer experts were significantly higher than those for non-medical academics (t(31) 6.8, P < 0.001). CAM scores were higher among students who received an intervention leaflet than the control leaflet (t(47) 4.8, P < 0.001).CONCLUSIONS: These studies show the psychometric properties of the CAM and support its validity as a measure of cancer awareness in the general population. British Journal of Cancer (2009) 101, S13-S17. doi: 10.1038/sj.bjc.6605385 www.bjcancer.com (C) 2009 Cancer Research UK
190 citations
••
University of Bristol1, King's College London2, Cairo University3, Children's of Alabama4, University Hospital of Wales5, Great Ormond Street Hospital6, St James's University Hospital7, Boston Children's Hospital8, Manchester Academic Health Science Centre9, Newcastle upon Tyne Hospitals NHS Foundation Trust10, University of Southampton11, St Thomas' Hospital12
TL;DR: Deep phenotyping combined with whole exome sequencing is an effective tool for early identification of SRNS etiology, yielding an evidence-based algorithm for clinical management.
190 citations
Authors
Showing all 12132 results
Name | H-index | Papers | Citations |
---|---|---|---|
David J. Hunter | 213 | 1836 | 207050 |
Rory Collins | 162 | 489 | 193407 |
Steven Williams | 144 | 1375 | 86712 |
Geoffrey Burnstock | 141 | 1488 | 99525 |
Nick C. Fox | 139 | 748 | 93036 |
Christopher D.M. Fletcher | 138 | 674 | 82484 |
David A. Jackson | 136 | 1095 | 68352 |
Paul Harrison | 133 | 1400 | 80539 |
Roberto Ferrari | 133 | 1654 | 103824 |
David Taylor | 131 | 2469 | 93220 |
Keith Hawton | 125 | 657 | 55138 |
Nicole Soranzo | 124 | 316 | 74494 |
Roger Williams | 122 | 1455 | 72416 |
John C. Chambers | 122 | 645 | 71028 |
Derek M. Yellon | 122 | 638 | 54319 |